New Neurological Findings and Documentation System Developed at Göttingen University

MEDNOVO Medical Software Solutions GmbHAn innovative neurological findings and documentation system named "NEMESYS" has been developed in the Department of Clinical Neurophysiology at Göttingen University School of Medicine. As regards content NEMESYS was developed in the Department of Clinical Neurophysiology at the University Hospital Göttingen (UKG) by Professor (Prof. Dr.) W. Paulus, Director of the Department of Clinical Neurophysiology, and private lecturer (Priv. Doz. Dr. med.) F. Tergau, St. Bernward Hospital in Hildesheim, formerly Department of Clinical Neurophysiology of the UKG. Technically NEMESYS was developed by Dipl. Phys. J. Lessing (Faculty of Physics).

From the left: Dipl.-Ing. Markus Mladek (MBM), Michael Heinlein (Managing Director  MEDNOVO Medical Software Solutions GmbH), Dr. Hans-Joachim Conrad (Executive Board of Management and Administration of the Göttingen University School of Medicine), Prof. Dr. Walter Paulus (Director of the Department of Clinical Neurophysiology)
From the left (Photo: umg): Dipl.-Ing. Markus Mladek (MBM), Michael Heinlein (Managing Director MEDNOVO Medical Software Solutions GmbH), Dr. Hans-Joachim Conrad (Executive Board of Management and Administration of the Göttingen University School of Medicine), Prof. Dr. Walter Paulus (Director of the Department of Clinical Neurophysiology).

MBM ScienceBridge GmbH, the technology transfer organization of Göttingen University, has been able to win the company MEDNOVO Medical software Solutions GmbH from Berlin as a licence partner for NEMESYS. "This partnership of science and economy again is a good example how our inhouse innovations are financially sensibly transformed into a marketable product for the single scientist and for Göttingen University", says Dr. Hans-Joachim Conrad, Executive Board of Management and Administration of the Göttingen University School of Medicine. The two partners have now signed a cooperation agreement.

NEMESYS is an absolute novelty in its function and its applicability in neurology: NEMESYS runs as a client-server-application on a database. By digital connection to neurological derivation devices (e.g. EEG, EMG), it is possible for the first time to work on different networked workplaces. Moreover, NEMESYS simplifies and standardizes the findings documentation in the area of Clinical Neurophysiology. The new system provides finding modules for the essential neurodiagnostical examination proceedings like EEG, EMG, EP, transcranial magnet stimulation, doppler-/ duplex sonography and EEG monitoring.

NEMESYS was certified by the German Society for Clinical Neurophysiology and Functional Imaging (DGKN). The extent of documentation as well as structure and classification of the findings modules were developed in arrangement with the DGKN and geared at international documentation standards.

Professor Walter Paulus, Director of the Department of Clinical Neurophysiology at the UKG: "We are pleased to have found an innovative partner like the company MEDNOVO, who will not only market but also enhance NEMESYS."

MEDNOVO offers the system NEMESYS as an additional module for its product family MediColor, an imaging and findings documentation system in functional diagnostics. Michael Heinlein, Managing Director of MEDNOVO Medical Software Solutions GmbH: "With the acquisition of NEMESYS we can complement the content of our system MediColor very well. In the near future, we will offer MediColor-Nemesys not only in Germany but also internationally."

NEMESYS is already in use at the University Hospital of the Georg-August-University Göttingen, at the Hospital Bremen-East, and at the Hospital of the Johannes-Gutenberg-University Mainz.

About the Department of Clinical Neurophysiology at Göttingen University
The main emphasis of the research at the Department of Clinical Neurophysiology at Göttingen University is focused on the field of epilepsy and Morbus Parkinson as well as on the further development of the methods documented in NEMESYS. Moreover, an English NEMESYS version shall carry this documentation standard also to the Anglo-Saxon countries. For further information, please visit www.neurologie.uni-goettingen.de

About MBM Science Bridge GmbH
The MBM Science Bridge GmbH is the technology transfer organization of the University and operates as a mediator between inventors and industry partners. For further information, please visit www.sciencebridge.de

About MEDNOVO Medical Software Solutions GmbH
The MEDNOVO Medical Software Solutions GmbH is specialized in the de-velopment of medical documentation systems and the connection and integration of medical devices with various hospital information systems (HIS). For further information, please visit www.mednovo.de

Most Popular Now

Accelerating NHS Digital Maturity: Paper…

Digitised clinical noting at South Tees Hospitals NHS Foundation Trust is creating efficiencies for busy doctors and nurses. The trust’s CCIO Dr Andrew Adair, deputy CCIO Dr John Greenaway, and...

AI Tool Helps Predict Who will Benefit f…

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who...

New Study Shows Promise for Gamified mHe…

A new study published in Multiple Sclerosis and Related Disorders highlights the potential of More Stamina, a gamified mobile health (mHealth) app designed to help people with Multiple Sclerosis (MS)...

AI in Healthcare: How do We Get from Hyp…

The Highland Marketing advisory board met to consider the government's enthusiasm for AI. To date, healthcare has mostly experimented with decision support tools, and their impact on the NHS and...

Research Shows AI Technology Improves Pa…

Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of assessment. That's partly because Parkinson's sibling movement disorders...

New AI Tool Accelerates Disease Treatmen…

University of Virginia School of Medicine scientists have created a computational tool to accelerate the development of new disease treatments. The tool goes beyond current artificial intelligence (AI) approaches by...

DMEA sparks: The Future of Digital Healt…

8 - 10 April 2025, Berlin, Germany. Digitalization is considered one of the key strategies for addressing the shortage of skilled workers - but the digital health sector also needs qualified...

First Therapy Chatbot Trial Shows AI can…

Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the software resulted in significant improvements in participants' symptoms, according to results...

Who's to Blame When AI Makes a Medi…

Assistive artificial intelligence technologies hold significant promise for transforming health care by aiding physicians in diagnosing, managing, and treating patients. However, the current trend of assistive AI implementation could actually...

DeepSeek: The "Watson" to Doct…

DeepSeek is an artificial intelligence (AI) platform built on deep learning and natural language processing (NLP) technologies. Its core products include the DeepSeek-R1 and DeepSeek-V3 models. Leveraging an efficient Mixture...

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...